Gynecologic Malignancies

Gita Suneja, Akila Viswanathan

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Gynecologic malignancies are among the most prevalent cancers affecting women worldwide, but they are heterogeneous diseases with varying risk factors, management paradigms, and outcomes. Gynecologic cancers mediated by human papillomavirus (HPV) are preventable and curable with early detection and treatment. Dramatic reductions in cervical cancer incidence and mortality have been achieved through cancer screening and HPV vaccination. Radiotherapy plays a central role in the management of gynecologic malignancies. For some cancers, radiotherapy alone can be curative. More often, radiotherapy is used in conjunction with surgery and systemic therapy to improve locoregional control and extend overall survival. This chapter reviews recent advances in radiotherapeutic management of gynecologic malignancies.

Original languageEnglish (US)
Pages (from-to)71-89
Number of pages19
JournalHematology/Oncology Clinics of North America
Issue number1
StatePublished - Feb 2020


  • Brachytherapy
  • Cervical cancer
  • Image guidance
  • Intensity modulated radiotherapy
  • Uterine cancer
  • Vulvar cancer

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Gynecologic Malignancies'. Together they form a unique fingerprint.

Cite this